Crawford & Company (CRD.B)
(Delayed Data from NYSE)
$11.68 USD
-0.32 (-2.67%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $11.65 -0.03 (-0.26%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.68 USD
-0.32 (-2.67%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $11.65 -0.03 (-0.26%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Zacks News
Is Accenture (ACN) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Accenture (ACN) and Crawford & Company B (CRD.B) have performed compared to their sector so far this year.
Crawford & Company B (CRD.B) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Crawford & Company B (CRD.B) closed at $8.12 in the latest trading session, marking a +0.37% move from the prior day.
Crawford & Company B (CRD.B) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Crawford & Company B (CRD.B) closed at $8.21 in the latest trading session, marking a +0.37% move from the prior day.
Zacks.com featured highlights include Riley Exploration Permian, Harrow Health, Crawford, Tecnoglass and Lantheus Holdings
by Zacks Equity Research
Riley Exploration Permian, Harrow Health, Crawford, Tecnoglass and Lantheus Holdings are part of the Zacks Screen of the Week article.
Crawford & Company B (CRD.B) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Crawford & Company B (CRD.B) closed at $8.21, marking a -1.02% move from the previous day.
Are Investors Undervaluing Crawford & Company (CRD.B) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Crawford & Company B (CRD.B) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Crawford & Company B (CRD.B) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
5 Stocks With Recent Price Strength to Maximize Your Gains
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are TGLS, CRD.B, REPX, HROW and LNTH.
Is Accenture (ACN) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Accenture (ACN) and Crawford & Company B (CRD.B) have performed compared to their sector so far this year.
Crawford & Company B (CRD.B) Stock Moves -0.37%: What You Should Know
by Zacks Equity Research
Crawford & Company B (CRD.B) closed the most recent trading day at $8, moving -0.37% from the previous trading session.
Are Investors Undervaluing Avis Budget Group (CAR) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Crawford & Company (CRD.A) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights Bellerophon Therapeutics, Crawford, Riley Exploration Permian, Harrow Health and Lantheus
by Zacks Equity Research
Bellerophon Therapeutics, Crawford, Riley Exploration Permian, Harrow Health and Lantheus have been highlighted in this Screen of The Week article.
5 Stocks With Recent Price Strength Amid March Rally
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are BLPH, CRD.B, REPX, HROW and LNTH.
Are Business Services Stocks Lagging Crawford & Company (CRD.B) This Year?
by Zacks Equity Research
Here is how Crawford & Company B (CRD.B) and Accenture (ACN) have performed compared to their sector so far this year.
Recent Price Trend in Crawford & Company B (CRD.B) is Your Friend, Here's Why
by Zacks Equity Research
Crawford & Company B (CRD.B) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Crawford & Company B (CRD.B) Soars 9.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Crawford & Company B (CRD.B) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Is Avis Budget Group (CAR) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Crawford & Company (CRD.A) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Avis Budget Group (CAR) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Business Services Stocks Lagging Cipher Mining (CIFR) This Year?
by Zacks Equity Research
Here is how Cipher Mining Inc. (CIFR) and Crawford & Company B (CRD.B) have performed compared to their sector so far this year.
Best Value Stocks to Buy for March 9th
by Zacks Equity Research
BIDU, CRD.B and KR made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 9, 2023.
Crawford & Company B (CRD.B) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Crawford & Company B (CRD.B) delivered earnings and revenue surprises of 35.29% and 6.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Everi Holdings (EVRI) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Everi Holdings (EVRI) delivered earnings and revenue surprises of 16.67% and 3.89%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ComScore (SCOR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
comScore (SCOR) delivered earnings and revenue surprises of 42.86% and 3.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?